EBR Systems, Inc.

EBR Systems, Inc. is a medical device company based in Silicon Valley, founded in 2003. The company specializes in innovative treatments for cardiac rhythm diseases, aiming to enhance cardiac rhythm management through a combination of clinical insights and technological advancements. Their flagship product, the WiSE System, is a leadless, wireless cardiac resynchronization therapy technology that provides a more physiologic approach to heart pacing. The company emphasizes core values such as patient-first care, positivity, leadership, and continuous improvement. EBR Systems has achieved significant milestones, including the first human clinical trial of the WiSE System in 2011 and FDA approval in 2025. Their technology is validated by pivotal clinical trials, demonstrating its effectiveness in improving patient outcomes. EBR Systems primarily serves healthcare professionals, including cardiologists and electrophysiologists, focusing on patients who may benefit from leadless pacing solutions in the cardiac device market.

• Employees 89
• Founded 2003
• Annual Revenue $678000
• Total Funding $259395722